Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gibberellin biosynthesis pathway is a critical metabolic sequence in plants responsible for the production of gibberellins (GAs), which are tetracyclic diterpenoid phytohormones essential for growth and development. These hormones regulate several key biological processes, including seed germination, stem elongation, leaf expansion, and the transition to flowering (Sun, 2008, Annual Review of Plant Biology). The pathway involves a series of enzymes located across different cellular compartments, such as the plastids, endoplasmic reticulum, and cytosol, with enzymes like ent-kaurene oxidase and GA 20-oxidase serving as major regulatory points (Hedden & Sponsel, 2015, Phytochemistry). In agricultural and horticultural practices, this pathway is a primary target for plant growth regulators (PGRs) that aim to manipulate plant stature and improve crop stability. Compounds such as paclobutrazol and prohexadione act as inhibitors of specific enzymatic steps in this pathway, effectively reducing active GA levels to prevent lodging in cereals and control the height of ornamental plants (Rademacher, 2000, Annual Review of Plant Physiology and Plant Molecular Biology). While vital for plant physiology, this biosynthetic pathway is absent in humans and is not considered a target for human clinical therapeutics.
Inhibition of specific biosynthetic enzymes, such as ent-kaurene oxidase or GA 20-oxidase, to decrease the endogenous levels of bioactive gibberellins.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gibberellin biosynthesis pathway (GA biosynthesis).